Provenance
Created by SPS, the British Association for Sexual Health and HIV (BASHH), the British Association of HIV (BHIVA) and the support of specialist stakeholders working within clinical practice for sexual health services.
Published versions
Version 3.0 of this PGD template, valid from February 2027, has been published to allow organisations to undertake local governance processes in a timely manner.
Version 2.0 of this PGD template remains currently valid and will be removed from this page on its expiry (31st January 2027).
PGD template attachment
The template PGD is attached below to download and use in conjunction with our implementation advice (SPS page).
More sexual health PGD templates
- Podophyllotoxin (topical) for external anogenital warts
- Imiquimod 5% w/w cream for anogenital warts
- Clotrimazole cream for candidiasis and candidal balanoposthitis
- Clotrimazole pessaries for candidiasis
- Fluconazole 150mg capsules for candidiasis
- Ceftriaxone intramuscular injection for Neisseria gonorrhoeae
- Metronidazole (oral) for use within sexual health services
- Emtricitabine and tenofovir disoproxil (TD) tablets as PrEP
- Doxycycline for use within sexual health services
- Azithromycin (oral) for use within sexual health services
- Doxycycline post exposure prophylaxis (doxyPEP)
- Emtricitabine/tenofovir and raltegravir tablets for HIV PEP
- Emtricitabine and tenofovir alafenamide (TAF) tablets as PrEP
All PGD templates
National PGD, protocol and written instructions templates
National templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.
Update history
- Republished
- Republished
- V3.0 template published. Explanatory text regarding versions published added.
- Republished
- PGD template attachment replaced to address formatting problems
- PGD template attachment replaced with new accessible version.
- Expired V1 PGD template removed
- Version 2.0 published
- Title, URL and summary amended.
- Published